Peer-reviewed veterinary case report
Epilobium parviflorum reduces prostate size in dogs with BPH
By Cazzuli, Guillermo et al.·Published in Veterinary medicine and science·2025·nicas y Hospital Veterinario·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Use of Epilobium parviflorum in the Treatment of Benign Prostatic Hyperplasia in Canines.
- Species:
- dog
Plain-English summary
A 7-year-old male dog with benign prostatic hyperplasia (BPH) was treated with an herbal extract called Epilobium parviflorum for two months. After starting the treatment, the dog's prostate size decreased by 40%, and there were no side effects noted during the treatment period. Additionally, the dog's testosterone levels also dropped, which can help manage BPH symptoms. This study suggests that Epilobium parviflorum could be a safe and effective option for dogs suffering from this condition.
People also search for: dog prostate problems treatment · benign prostatic hyperplasia in dogs · herbal remedies for dog BPH
Abstract
The objective of the study was to evaluate the effect of Epilobium parviflorum (EP) as a treatment for benign prostatic hyperplasia (BPH) in dogs based on two clinical case reports. Two dogs with BPH were treated for 2 months with EP extract. For both cases, follow-up was performed with B-mode ultrasound on Days 7, 15, 30 and 60 after starting treatment, and measurements of the length, width and height of the prostate were taken to calculate its volume (cm). A complete blood count, liver and kidney biochemistry, urinalysis and serum testosterone concentration (ng/dL) were completed at the same time points. EP was well tolerated with no side effects observed during the 60-day oral administration period. In both cases, prostate volume decreased by 40% (Case 1: 81-50 cm; Case 2: 79-44 cm) by Day 60. Serum testosterone concentration decreased by 30% for Case 1 (749-512 ng/dL) and 20% for Case 2 (220-188 ng/dL). This case report describes an alternative therapeutic method effective for treating canine BPH without apparent adverse reactions or complications.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40033986/